Angelo De Marzo, M.D., Ph.D., currently serves as chief medical officer for Predictive Biosciences Inc., which is a molecular diagnostics company focusing on genitourinary cancer. Previously, he was a professor of pathology, oncology and urology and a member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, where he still maintains a part-time adjunct faculty position.
Dr. De Marzo received his undergraduate, medical and graduate degrees from the University of Colorado. He completed a residency in anatomic pathology at The Johns Hopkins University School of Medicine in 1997 and since 1998 he has been a practicing board-certified urological pathologist, focusing extensively on prostate pathology. His research at Johns Hopkins focused on the molecular mechanisms involved in cancer initiation and progression, as well as the role of inflammation in prostate cancer. He also performed clinical diagnostic, prognostic and predictive biomarker research in urological cancers.
Dr. De Marzo has published more than 200 articles, has served on a number of NIH grant review panels, is a former member of the Department of Defense Prostate Cancer Research Program (PCRP) Integration Panel, and currently serves on the editorial board for the journals The Prostate and Cancer Prevention Research.